Your browser doesn't support javascript.
loading
Secukinumab demonstrates efficacy, safety, and tolerability upon administration by 2 ml autoinjector in adult patients with plaque psoriasis: 52-week results from MATURE, a randomized, placebo-controlled trial.
Sigurgeirsson, Bardur; Browning, John; Tyring, Stephen; Szepietowski, Jacek C; Rivera-Díaz, Raquel; Effendy, Isaak; Keefe, Deborah; Bruin, Gerard; Paguet, Bertrand; Fu, Rong; Hampele, Isabelle; Reinhardt, Maximilian; Patekar, Manmath.
Afiliación
  • Sigurgeirsson B; Faculty of Medicine, Department of Dermatology, University of Iceland, Reykjavík, Iceland.
  • Browning J; Department of Dermatology, University of Texas Health Science Center San Antonio, Texas, USA.
  • Tyring S; Center for Clinical Studies, Houston, Texas, USA.
  • Szepietowski JC; Department of Dermatology, Venereology and Allergology, Wroclaw Medical University, Wroclaw, Poland.
  • Rivera-Díaz R; Hospital Universitario 12 de Octubre, Madrid, Spain.
  • Effendy I; Departrment of Dermatology and Allergology, University Hospital of Bielefeld, Bielefeld, Germany.
  • Keefe D; Immunology, Hepatology and Dermatology (IH&D), Novartis Pharmaceuticals Corporation, New Jersey, USA.
  • Bruin G; Immunology, Hepatology and Dermatology (IH&D), Novartis Institutes for Biomedical Research, Basel, Switzerland.
  • Paguet B; Immunology, Hepatology and Dermatology (IH&D), Novartis Pharma AG, Basel, Switzerland.
  • Fu R; Analytics, Immunology, Hepatology and Dermatology (IH&D), Novartis Institutes of for Biomedical Research, Shanghai, China.
  • Hampele I; Immunology, Hepatology and Dermatology (IH&D), Novartis Pharma AG, Basel, Switzerland.
  • Reinhardt M; Immunology, Hepatology and Dermatology (IH&D), Novartis Pharma AG, Basel, Switzerland.
  • Patekar M; Immunology, Hepatology and Dermatology (IH&D), Novartis Pharma AG, Basel, Switzerland.
Dermatol Ther ; 35(3): e15285, 2022 03.
Article en En | MEDLINE | ID: mdl-34954841

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Psoriasis / Anticuerpos Monoclonales Tipo de estudio: Clinical_trials / Diagnostic_studies Límite: Adult / Humans Idioma: En Revista: Dermatol Ther Asunto de la revista: DERMATOLOGIA Año: 2022 Tipo del documento: Article País de afiliación: Islandia Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Psoriasis / Anticuerpos Monoclonales Tipo de estudio: Clinical_trials / Diagnostic_studies Límite: Adult / Humans Idioma: En Revista: Dermatol Ther Asunto de la revista: DERMATOLOGIA Año: 2022 Tipo del documento: Article País de afiliación: Islandia Pais de publicación: Estados Unidos